Facial Hyperpigmentation
2 clinical trials · Condition
◉ Watch Facial Hyperpigmentation
| Record | Firm | Date |
|---|---|---|
| Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation (NCT03926845) | Institute of Dermatology, Thailand | 2019-04-29 |
Track Facial Hyperpigmentation automatically
Every clearance here is in the API, with alerts when new ones post.